FindMyKOL
Clinical trialNCT04737460Active, not recruitingPhase 1Interventional

Study for the Treatment for CLN7 Disease

NCT04737460 is a phase 1 interventional trial sponsored by Benjamin Greenberg. As of 21 Nov 2026, it is active and no longer recruiting. It studies CLN7. The registry lists an enrollment of 4 participants at 1 site in 1 country. The registry lists a start date of 4 May 2021 and a primary completion date of 1 Feb 2028.

SponsorBenjamin GreenbergEnrollment4CLN7
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04737460
FieldValue
Registry IDNCT04737460
StatusActive not recruiting
PhasePhase 1
Study typeInterventional trial
Lead sponsorBenjamin Greenberg
Enrollment4
Registered sites1
Countries1
ConditionsCLN7
Start4 May 2021
Primary completion1 Feb 2028
Study completion1 Feb 2029
Last update posted31 Dec 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase 1 open-label, single-administration of gene therapy agent AAV9/CLN7, administered intrathecally into the lumbar spinal cord region of pediatric patients with CLN7 Batten disease. This study consists of a one-time injection of AAV9/CLN7. There are two Cohorts with a low dose and a high dose. The primary objective for this clinical study is to evaluate safety. The secondary objective is to determine the efficacy of AAV9/CLN7. The secondary outcome measures include motor, cognition and intelligence assessments. The exploratory outcome measures include visual impairment assessment, cognitive evaluations, Brain magnetic resonance imaging (MRI), electroencephalogram (EEG), electrocardiogram (ECG) and echocardiogram (ECHO).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Benjamin Greenberg, MD

    University of Texas Southwestern Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site
  • Children' Health

    Dallas

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04737460

Each answer restates registry values shown on this page.

What is NCT04737460?

NCT04737460 is a phase 1 interventional trial sponsored by Benjamin Greenberg. It studies CLN7.

Is NCT04737460 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT04737460?

The registry names Benjamin Greenberg, MD (principal investigator, University of Texas Southwestern Medical Center) as the overall official.

Where does NCT04737460 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT04737460 expected to complete?

The registry lists a primary completion date of 1 Feb 2028 and a study completion date of 1 Feb 2029. The sponsor last updated the record on 31 Dec 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.